- Home
- RXRX vs MRX Comparison
RXRX vs MRX Comparison
Compare RXRX & MRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- MRX
- Stock Information
- Founded
- RXRX 2013
- MRX 2005
- Country
- RXRX United States
- MRX United Kingdom
- Employees
- RXRX N/A
- MRX N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- MRX
- Sector
- RXRX Health Care
- MRX
- Exchange
- RXRX Nasdaq
- MRX NYSE
- Market Cap
- RXRX 2.6B
- MRX 2.5B
- IPO Year
- RXRX 2021
- MRX 2024
- Fundamental
- Price
- RXRX $4.33
- MRX $47.38
- Analyst Decision
- RXRX Buy
- MRX Strong Buy
- Analyst Count
- RXRX 5
- MRX 8
- Target Price
- RXRX $7.60
- MRX $35.25
- AVG Volume (30 Days)
- RXRX 22.1M
- MRX 1.3M
- Earning Date
- RXRX 05-05-2025
- MRX 05-15-2025
- Dividend Yield
- RXRX N/A
- MRX 0.88%
- EPS Growth
- RXRX N/A
- MRX 49.45
- EPS
- RXRX N/A
- MRX 2.72
- Revenue
- RXRX $59,790,000.00
- MRX $2,356,700,000.00
- Revenue This Year
- RXRX $57.30
- MRX N/A
- Revenue Next Year
- RXRX $51.53
- MRX $8.84
- P/E Ratio
- RXRX N/A
- MRX $17.46
- Revenue Growth
- RXRX 29.32
- MRX 25.22
- 52 Week Low
- RXRX $3.79
- MRX $18.13
- 52 Week High
- RXRX $12.36
- MRX $48.91
- Technical
- Relative Strength Index (RSI)
- RXRX 36.37
- MRX N/A
- Support Level
- RXRX $4.11
- MRX N/A
- Resistance Level
- RXRX $5.90
- MRX N/A
- Average True Range (ATR)
- RXRX 0.39
- MRX 0.00
- MACD
- RXRX -0.11
- MRX 0.00
- Stochastic Oscillator
- RXRX 11.00
- MRX 0.00
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About MRX MAREX GROUP PLC
Marex Group PLC is a company that offers a diversified global financial services platform providing essential liquidity, market access and infrastructure services to clients across energy, commodities and financial markets. It provides critical services to the clients by connecting them to global exchanges and providing a range of execution and hedging services across a range of its asset and products. They operate in a large and fragmented market with significant infrastructure requirements and regulatory and technological complexity, resulting in high barriers to entry.